Statement Of Changes In Equity [Abstract]

Heidelberg Pharma AG - Filing #6821989

Concept As at
2021-11-30
2020-12-01 to
2021-11-30
As at
2021-11-30
2020-12-01 to
2021-11-30
As at
2021-11-30
As at
2021-11-30
2020-12-01 to
2021-11-30
2020-12-01 to
2021-11-30
2020-12-01 to
2021-11-30
As at
2021-11-30
As at
2021-11-30
As at
2020-11-30
As at
2020-11-30
2019-12-01 to
2020-11-30
2019-12-01 to
2020-11-30
As at
2020-11-30
2019-12-01 to
2020-11-30
2019-12-01 to
2020-11-30
As at
2020-11-30
As at
2020-11-30
2019-12-01 to
2020-11-30
As at
2020-11-30
As at
2019-11-30
As at
2019-11-30
As at
2019-11-30
As at
2019-11-30
As at
2019-11-30
As at
2019-11-30
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
238.054.927 EUR
6.160.373 EUR
34.175.809 EUR
244.215.300 EUR
6.698.731 EUR
271.692.378 EUR
227.370.862 EUR
31.061.872 EUR
5.473.884 EUR
245.553.676 EUR
221.896.978 EUR
12.879.058 EUR
16.293.420 EUR
28.209.611 EUR
215.268.448 EUR
4.903.988 EUR
210.364.460 EUR
227.184.639 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
26.138.702 EUR
26.138.702 EUR
18.369.038 EUR
18.369.038 EUR
Issue of equity
3.106.637 EUR
16.151.452 EUR
19.258.089 EUR
2.820.961 EUR
11.504.661 EUR
14.325.622 EUR
Increase (decrease) through share-based payment transactions, equity
686 EUR
686 EUR
570 EUR
570 EUR
Increase (decrease) in equity
6.180.327 EUR
3.414.362 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.